The Scientist

» clinical trials and immunology

Most Recent

image: Amoebae Have Human-Like Immunity

Amoebae Have Human-Like Immunity

By | March 2, 2016

Dictyostelium discoideum produce extracellular nets that can kill bacteria, just as phagocytes in people and other higher animals do, according to a study.

0 Comments

image: Giant Virus Has CRISPR-like Immune Defense

Giant Virus Has CRISPR-like Immune Defense

By | March 2, 2016

The genome of a mimivirus strain resistant to a virophage has repeated phage sequences alongside nuclease- and helicase-coding sections.

1 Comment

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

0 Comments

image: Cautious Optimism About ZMapp Trial

Cautious Optimism About ZMapp Trial

By | February 25, 2016

The Ebola drug increased survival in a small study, but the effect was not statistically significant.

0 Comments

image: Mutations Not Tied to Metastasis

Mutations Not Tied to Metastasis

By | February 25, 2016

Clinical cases link immune changes to a cancer’s spread through the body, but find no role for so-called “driver” mutations.

3 Comments

image: Single Antibody Protects Macaques from Ebola

Single Antibody Protects Macaques from Ebola

By | February 25, 2016

The “just right” binding properties of a monoclonal antibody from an Ebolavirus survivor help it neutralize the virus.

0 Comments

image: Anti-Inflammatory Drugs as Antivenom?

Anti-Inflammatory Drugs as Antivenom?

By | February 24, 2016

Compounds typically used to calm the immune system can prevent death from scorpion venom in mice, researchers report.

0 Comments

image: Opinion: Why Most TBI Studies Fail

Opinion: Why Most TBI Studies Fail

By | February 24, 2016

Thoughts on how to redesign clinical trials for traumatic brain injury

1 Comment

image: Premature Assault?

Premature Assault?

By | February 9, 2016

Plants may trick bacteria into attacking before the microbial population reaches a critical size, allowing the plants to successfully defend the weak invasion.

0 Comments

image: In Situ Antibodies

In Situ Antibodies

By | February 2, 2016

Compared with systemic injections, localized antibody therapies may be more effective for some indications.

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech